| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8223758 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Our results confirm the isoeffectiveness of the 2 fractionation schedules used in this study, although a benefit in favor of hypofractionation cannot be excluded in the subgroup of patients with an iPSA level of 20 ng/mL or less. The α/β ratio might be more appropriately evaluated by FFLF than FFBF results, at least in high-risk disease.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stefano MD, Lidia PhD, Sara MD, Biancamaria MD, Maria Grazia MD, Paola MD, Valentina MD, Giorgio MD,